|By PR Newswire||
|January 13, 2013 07:01 PM EST||
LONDON, January 14, 2013 /PRNewswire/ --
Souvenaid, a "Food for Special Medical Purposes" for the dietary management of early Alzheimer's disease
From today, Souvenaid, a unique 125ml once-a-day drink, is available for people living with early Alzheimer's disease. This over-the-counter innovative product is the result of over 10 years' research into the nutritional needs of people living with the early stages of the disease.
Around 800,000 people in the UK live with dementia,1 of which Alzheimer's disease is the most common form. It is a growing health problem in an aging population, leading the government to prioritise earlier diagnosis of the condition.
The loss of connections in the brain (synapses) is one of the key features of early Alzheimer's disease. A combination of nutrients are required in the process of making new connections and people living with Alzheimer's disease have been shown to have relatively low levels of these nutrients in their bodies despite eating a normal diet.2,3,4,5,6,7
This adds to a growing body of evidence that highlights how nutrition can help manage the disease in the early stages.8,9,10,11,12,13
Dr David Wilkinson, Consultant in Old Age Psychiatry, commented: "Alzheimer's disease is not part and parcel of aging but a serious and progressive disease of the brain which prevents us from being able to retain new memories. As we age, our bodies become less efficient at processing essential nutrients, meaning that we need to increase our intake of food to absorb the same amount of nutrients in order to maintain a healthy body. In the same way, we need the right nutrients for our brains to keep them healthy.
"Alzheimer's disease sufferers often find it very difficult to get everything they need through diet alone and the nutritional intervention by the use of Souvenaid is a new area of research offering promising results for the management of early Alzheimer's disease."
The current healthcare provision for people with early Alzheimer's disease fails to reflect the important role that nutrition can play in managing the disease. A recent survey of specialists involved in the diagnosis of Alzheimer's disease showed that only a third (33%) regularly assess patients' nutritional status during the diagnostic process.14 Two-thirds of specialists do not even have access to a dietician for these patients.14
Often, after a diagnosis of Alzheimer's disease, it can be difficult to stay positive, particularly when there is little to offer in the way of effective early interventions. Souvenaid offers a new option for people living with early-stage Alzheimer's disease.
Barbara Stephens, Dementia UK Chief Executive, commented: "A diagnosis of dementia is devastating both for those with the condition and their families and carers. Early-stage intervention is important for maximising choices and enabling people with dementia and their carers to lead healthier lives for longer."
Souvenaid contains a unique combination of nutrients that are naturally present in food, at levels difficult to achieve from diet alone. It contains: omega-3 polyunsaturated fatty acids (docosahexaenoic acid (DHA), eicosapentaenoic acid [EPA]), uridine (as uridine monophosphate [UMP]) and choline, together with phospholipids and B vitamins. Souvenaid comes in two tasty flavours (vanilla and strawberry) and tastes best served chilled. Souvenaid is designed to be incorporated into the daily routine, for example, by taking it at breakfast time.
Souvenaid is a Food for Special Medical Purposes, for the dietary management of early Alzheimer's disease. It is available over-the-counter from local accredited pharmacists. People with early Alzheimer's disease must speak with a doctor, specialist nurse, dietician or pharmacist to see if Souvenaid is right for them.
Please visit http://www.souvenaid.com for more information.
Notes to Editors
About Nutricia Advanced Medical Nutrition
- Nutricia is the leading medical nutrition company in Europe. It is part of Danone, one of the fastest-growing food and nutrition companies in the world.
- Nutricia aims to bring health through medical nutrition to those people who most need it, focusing on people with disease- or age-related nutritional needs.
- Nutricia has an extensive portfolio of products and services, catering from nutritional needs in metabolic conditions such as phenylketonuria (PKU), to non-metabolic conditions such as allergy and epilepsy, to disease-related malnutrition and frailty.
- Through its Homeward service and 100 dedicated nurses, Nutricia supports over 20,000 people in the UK who require enteral nutrition (tube feeding) support in their own homes.
- Designed to be taken daily.
- A 125ml daily drink, available in two tasty flavours, vanilla and strawberry.
- A food for special medical purposes and must be used under medical supervision.
- Available from 14th January 2013 in accredited pharmacies in England, Wales and Scotland, and via http://www.souvenaid.com.
- Gluten and lactose free.
- A unique combination of nutrients including omega-3 polyunsaturated fatty acids (docosahexaenoic acid, DHA and eicosapentaenoic acid (EPA)), uridine (as uridine monophosphate (UMP)) and choline, together with phospholipids and B vitamins. Whilst such nutrients are naturally present in food, such levels are difficult to achieve from diet alone.
The safety and efficacy of Souvenaid has been studied in several clinical trials.7,15,16 A further study in prodromal (non-symptomatic Alzheimer's disease) is currently underway. This trial is wholly funded by the European Union.17
Please visit http://www.souvenaid.com for more information.
1. Alzheimer's Society. Statistics [Online] http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=341 [Accessed December 2012].
2. Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010;5:45-61.
3. Smach MA, Jacob N, Golmard J-L et al. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur. Neurol. 2011;65(5):270-8.
4. Glasø M, Nordbø G, Diep L, Bøhmer T. Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutr Health Aging. 2004;8(5):407-13.
5. Lopes da Silva S, Elemans S et al. Plasma nutrient status of Alzheimer's disease patients compared to cognitive intact elderly controls; a systematic review and meta-analysis. Alzheimers Dement 2012; 8(4):Supple 2 216.
6. Sijben J, Olde Rikkert MG et al. Different nutritional status in patients with mild Alzheimer's disease compared to healthy controls. Eur J Neurol 2012; in press.
7. Scheltens P, Twisk JW, Blesa R et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis. 2012; 31:225-36.
8. Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 2003; 60(7):940-6.
9. Sydenham E, Dangour AD, Lim W-S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012; 6:CD005379.
10. Gu Y, Nieves JW, Stern Y et al. Food combination and Alzheimer disease risk: a protective diet. Arch. Neurol. 2010; 67(6):699-706.
11. Zandi PP, Anthony JC, Khachaturian AS et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 2004; 61(1):82-8.
12. Quadri P, Fragiacomo C, Pezzati R et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 2004; 80(1):114-122.
13. Sachdev PS. Homocysteine and brain atrophy. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005; 29(7):1152-1161.
14. 100 specialists were surveyed online. Fieldwork was conducted by MedeConnect Healthcare Insight 2-16 November 2012.
15. Scheltens P, Kamphuis PJ, Verhey F et al. Efficacy of a medical food in mild Alzheimer's Disease: a randomized controlled trial.
Alzheimer's & Dementia. 2010;6:1-10.
16. Shah R et al. Souvenaid® as an add-on intervention in patients with mild to moderate Alzheimer's disease using Alzheimer's disease medication: results from a randomized, controlled, double-blind study (S-Connect). CTAD, San Diego, November 2011; J Nutr Health Aging (Nov suppl.).
17. European Commission website. LipiDiDiet: http:ec.europa.eu/research/bioeconomy/lipidiet_en.htm [Accessed December 2012].
Today air travel is a minefield of delays, hassles and customer disappointment. Airlines struggle to revitalize the experience. GE and M2Mi will demonstrate practical examples of how IoT solutions are helping airlines bring back personalization, reduce trip time and improve reliability. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Dr. Sarah Cooper, M2Mi’s VP Business Development and Engineering, explored the IoT cloud-based platform technologies driving t...
Nov. 30, 2015 02:00 AM EST Reads: 445
I recently attended and was a speaker at the 4th International Internet of @ThingsExpo at the Santa Clara Convention Center. I also had the opportunity to attend this event last year and I wrote a blog from that show talking about how the “Enterprise Impact of IoT” was a key theme of last year’s show. I was curious to see if the same theme would still resonate 365 days later and what, if any, changes I would see in the content presented.
Nov. 30, 2015 02:00 AM EST Reads: 445
Cloud computing delivers on-demand resources that provide businesses with flexibility and cost-savings. The challenge in moving workloads to the cloud has been the cost and complexity of ensuring the initial and ongoing security and regulatory (PCI, HIPAA, FFIEC) compliance across private and public clouds. Manual security compliance is slow, prone to human error, and represents over 50% of the cost of managing cloud applications. Determining how to automate cloud security compliance is critical...
Nov. 30, 2015 12:00 AM EST Reads: 449
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ab...
Nov. 30, 2015 12:00 AM EST Reads: 418
As organizations shift towards IT-as-a-service models, the need for managing & protecting data residing across physical, virtual, and now cloud environments grows with it. CommVault can ensure protection & E-Discovery of your data - whether in a private cloud, a Service Provider delivered public cloud, or a hybrid cloud environment – across the heterogeneous enterprise.
Nov. 29, 2015 06:00 PM EST Reads: 235
In his General Session at DevOps Summit, Asaf Yigal, Co-Founder & VP of Product at Logz.io, explored the value of Kibana 4 for log analysis and provided a hands-on tutorial on how to set up Kibana 4 and get the most out of Apache log files. He examined three use cases: IT operations, business intelligence, and security and compliance. Asaf Yigal is co-founder and VP of Product at log analytics software company Logz.io. In the past, he was co-founder of social-trading platform Currensee, which...
Nov. 29, 2015 04:00 PM EST Reads: 255
The Internet of Things (IoT) is growing rapidly by extending current technologies, products and networks. By 2020, Cisco estimates there will be 50 billion connected devices. Gartner has forecast revenues of over $300 billion, just to IoT suppliers. Now is the time to figure out how you’ll make money – not just create innovative products. With hundreds of new products and companies jumping into the IoT fray every month, there’s no shortage of innovation. Despite this, McKinsey/VisionMobile data...
Nov. 29, 2015 02:00 PM EST Reads: 487
Just over a week ago I received a long and loud sustained applause for a presentation I delivered at this year’s Cloud Expo in Santa Clara. I was extremely pleased with the turnout and had some very good conversations with many of the attendees. Over the next few days I had many more meaningful conversations and was not only happy with the results but also learned a few new things. Here is everything I learned in those three days distilled into three short points.
Nov. 29, 2015 01:00 PM EST Reads: 358
DevOps is about increasing efficiency, but nothing is more inefficient than building the same application twice. However, this is a routine occurrence with enterprise applications that need both a rich desktop web interface and strong mobile support. With recent technological advances from Isomorphic Software and others, rich desktop and tuned mobile experiences can now be created with a single codebase – without compromising functionality, performance or usability. In his session at DevOps Su...
Nov. 29, 2015 12:45 PM EST Reads: 421
As organizations realize the scope of the Internet of Things, gaining key insights from Big Data, through the use of advanced analytics, becomes crucial. However, IoT also creates the need for petabyte scale storage of data from millions of devices. A new type of Storage is required which seamlessly integrates robust data analytics with massive scale. These storage systems will act as “smart systems” provide in-place analytics that speed discovery and enable businesses to quickly derive meaningf...
Nov. 29, 2015 12:30 PM EST Reads: 427
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
Nov. 29, 2015 12:00 PM EST Reads: 528
In his General Session at 17th Cloud Expo, Bruce Swann, Senior Product Marketing Manager for Adobe Campaign, explored the key ingredients of cross-channel marketing in a digital world. Learn how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects).
Nov. 29, 2015 11:45 AM EST Reads: 331
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
Nov. 29, 2015 11:30 AM EST Reads: 276
In recent years, at least 40% of companies using cloud applications have experienced data loss. One of the best prevention against cloud data loss is backing up your cloud data. In his General Session at 17th Cloud Expo, Sam McIntyre, Partner Enablement Specialist at eFolder, presented how organizations can use eFolder Cloudfinder to automate backups of cloud application data. He also demonstrated how easy it is to search and restore cloud application data using Cloudfinder.
Nov. 29, 2015 10:00 AM EST Reads: 204
The Internet of Everything is re-shaping technology trends–moving away from “request/response” architecture to an “always-on” Streaming Web where data is in constant motion and secure, reliable communication is an absolute necessity. As more and more THINGS go online, the challenges that developers will need to address will only increase exponentially. In his session at @ThingsExpo, Todd Greene, Founder & CEO of PubNub, exploreed the current state of IoT connectivity and review key trends and t...
Nov. 29, 2015 09:45 AM EST Reads: 454